16.92
前日終値:
$18.37
開ける:
$18.67
24時間の取引高:
319.99K
Relative Volume:
17.74
時価総額:
$761.05M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
Maplight Therapeutics Inc Stock (MPLT) Company Profile
MPLT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
MPLT
Maplight Therapeutics Inc
|
16.92 | 761.05M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Maplight Therapeutics Inc (MPLT) 最新ニュース
MapLight Therapeutics, Inc. (MPLT) Stock Major Holders - Yahoo! Finance Canada
Finance Watch: MapLight Brings US Biopharma IPO Tally To 11 In 2025 - Citeline News & Insights
MapLight Therapeutics Closes Successful IPO and Private Placement - MSN
Major Investment Alert: A S Novo’s Multi-Million Dollar Bet on MapLight Therapeutics! - TipRanks
Drug developer Evommune to go public next week, following MapLight's successful IPO - The Business Journals
Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO - MSN
MapLight Therapeutics completes $296 million IPO on nasdaq - Investing.com
Catalyst4, Inc. Makes a Major Move with a Massive Stock Purchase in MapLight Therapeutics! - TipRanks
MapLight Therapeutics, Inc. (MPLT) Latest Stock News & Headlines - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Stock Forum & Discussion - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Interactive Stock Chart - Yahoo! Finance Canada
MapLight Therapeutics completes $296 million IPO on nasdaq By Investing.com - Investing.com Nigeria
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Benzinga
Total liabilities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Diluted earnings per share (diluted EPS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Revenue Breakdown – NASDAQ:MPLT - TradingView
Total liabilities & shareholders' equities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Operating income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Net debt of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Operating expenses (excl. COGS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Taxes of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Financial Statements – NASDAQ:MPLT - TradingView
Total revenue of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Total operating expenses of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Gross profit of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
After tax other income/expense of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Earnings and Revenue – NASDAQ:MPLT - TradingView
EBITDA margin % of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Balance Sheet – NASDAQ:MPLT - TradingView
Non-controlling/minority interest of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Muscarinic path still charting as Maplight IPO gets $258M - BioWorld MedTech
MapLight Therapeutics, Inc. Income Statement – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Statistics – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. (MPLT) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Company Profile & Facts - Yahoo! Finance Canada
MPLT: Static price chart | MapLight Therapeutics, Inc. | US56565P1030 - MarketScreener
MapLight Therapeutics announces pricing of IPO - The Pharma Letter
Sergey Brin nonprofit gets $261 million lift in MapLight IPO - Crain Currency
MapLight shares track up after $251m IPO - pharmaphorum
MapLight Therapeutics, Inc. (MPLT) Options Chain - Yahoo! Finance Canada
Latham & Watkins Advises on MapLight Therapeutics’ Initial Public Offering - Legal Desire Media and Insights
MapLight Therapeutics, Inc.(NasdaqGS: MPLT) added to NASDAQ Composite Index - MarketScreener
MapLight Therapeutics Inc. (MPLT): Oversubscribed Neuroscience IPO Launches with a Bright Start - Smartkarma
Sergey Brin Nonprofit Gets a $242 Million Lift From MapLight IPO - Bloomberg.com
Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO (2) - Bloomberg Law News
Biotech MapLight Jumps 23% in First US IPO Using Shutdown Fix - Bloomberg.com
Biotech Firm MapLight Inks $251M IPO Amid Shutdown - Law360
MapLight Therapeutics raises $258M in IPO, private placement - Axios
CNS drug developer MapLight goes public, stock up 9% on first day of trading - The Business Journals
Novo-backed MapLight valued at $787 million after shares jump in Nasdaq debut - Yahoo Finance
Maplight Therapeutics Inc (MPLT) 財務データ
Maplight Therapeutics Inc (MPLT) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):